title: Unilateral naevoid telangiectasia in a young man after chemotherapy: a simple coincidence or a new clinical association?
authors.forename: M
authors.initials: M
authors.lastname: Rodríguez-Martín
authors.forename: M
authors.initials: M
authors.lastname: Sáez
authors.forename: A
authors.initials: A
authors.lastname: Carnerero
authors.forename: M
authors.initials: M
authors.lastname: García-Bustínduy
authors.forename: F
authors.initials: F
authors.lastname: Guimerá
authors.forename: F Rodríguez
authors.initials: FR
authors.lastname: García
authors.forename: R
authors.initials: R
authors.lastname: Cabrera de Paz
authors.forename: M
authors.initials: M
authors.lastname: Sidro
authors.forename: R
authors.initials: R
authors.lastname: Sánchez
authors.forename: A Martín
authors.initials: AM
authors.lastname: Herrera
authors.forename: A
authors.initials: A
authors.lastname: Noda
mesh_terms: D000328:Adult; D001761:Bleomycin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008297:Male; D013684:Telangiectasis / Q000139:chemically induced*; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D004317:Doxorubicin